Evidence map›Paper›PMID 31695156›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

Prospective molecular and morphological assessment of testicular prepubertal-type teratomas in postpubertal men.

Thomas Wagner, Glenda Scandura, Amy Roe, Luis Beltran, Jonathan Shamash, Costantine Alfrangis, Gedske Daugaard, Marianne Grantham, Daniel Berney

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Germ cell tumors in children.Virchows Archiv : an international journal of pathology · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Thomas WagnerDepartment of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-0256-0074
Glenda ScanduraDepartment of Molecular Oncology, Barts Cancer Institute, Charterhouse Square, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0002-0537-5894
Amy RoeDepartments of Cytogenetics and Molecular Haematology, Barts Health NHS Trust, The Royal London Hospital, London, UK.
Luis BeltranDepartment of Cellular Pathology, Barts Health NHS Trust, The Royal London Hospital, London, UK.
Jonathan ShamashDepartment of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
Costantine AlfrangisDepartment of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, London, UK.
Gedske DaugaardDepartment of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Marianne GranthamDepartments of Cytogenetics and Molecular Haematology, Barts Health NHS Trust, The Royal London Hospital, London, UK.
Daniel BerneyDepartment of Molecular Oncology, Barts Cancer Institute, Charterhouse Square, Queen Mary University of London, London, UK. Daniel.berney@nhs.net.ORCID http://orcid.org/0000-0001-5474-8696
Barts Health NHS Trust · GBCopenhagen University Hospital · DKQueen Mary University of London · GBSt Bartholomew's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2016, the World Health Organization classification system of testicular tumors included the new entity prepubertal-type teratoma based on its morphological and molecular profile, and the realization that these tumors may occur in postpubertal men. For treatment and prognostic purposes, it is important to distinguish prepubertal-type teratoma from the usual postpubertal-type teratoma, because the former is benign unlike the latter. The distinction may be challenging. In this study, we investigated clinical, morphological, and molecular criteria for distinguishing prepubertal-type teratoma from postpubertal-type teratoma in a prospective series of pure testicular teratomas. All cases of pure teratoma in postpubertal men assessed at Barts Health NHS Trust or in consultation since the introduction of routine investigation of chromosome 12p status in 2010 were reviewed. Morphological features suggestive of prepubertal-type teratoma were observed in 14 out of 35 cases. All underwent molecular testing and none displayed 12p amplification. Mean tumor size was 16 mm (range 7-28 mm). None had associated germ cell neoplasia in situ or significant atrophy. Four incorporated a well-differentiated neuroendocrine tumor, 1-2 mm in size. Of the ten patients with follow-up information, none have recurred or metastasized. Twenty-one of the 35 cases were diagnosed as postpubertal-type teratoma, mean tumor size 40 mm (range 6-90 mm). One case underwent molecular testing: a tumor of pure skeletal muscle differentiation and possessed 12p amplification. Three cases presented with clinical metastases. Eight cases contained immature areas, ten cases had associated germ cell neoplasia in situ, and 17 cases had severe atrophy of the parenchyma. One case with neither germ cell neoplasia in situ nor atrophy showed necrosis. We conclude that both morphological and molecular features are of help in differentiating prepubertal-type teratoma from postpubertal-type teratoma. In nearly all postpubertal-type teratomas, molecular testing was unnecessary, and merely confirmed the morphological impression in the prepubertal-type teratomas. Our study confirmed the high incidence of well-differentiated neuroendocrine tumors in the prepubertal-type.

Indexed as

PubertyAdultAgedBiomarkers, TumorBiopsyCell DifferentiationDiagnosis, DifferentialGenetic Predisposition to DiseaseHumansImmunohistochemistryMaleMiddle AgedMolecular Diagnostic TechniquesPhenotypePredictive Value of TestsProspective StudiesBiomarkers, Tumor

Identifiers

PMID31695156
OpenAlexW2989127418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.